中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
23期
92-93
,共2页
老年2型糖尿病%沙格列汀%门冬胰岛素30注射液
老年2型糖尿病%沙格列汀%門鼕胰島素30註射液
노년2형당뇨병%사격렬정%문동이도소30주사액
Elderly type 2 diabetes%Shah Glenn Dean%Insulin Aspart 30 Injection
目的：探究老年2型糖尿病采用沙格列汀联合门冬胰岛素30注射液治疗的临床疗效。方法选取72例老年2型糖尿病患者随机分为对照组和治疗组各组均36例，分别采用门冬胰岛素30注射液和沙格列汀联合门冬胰岛素30注射液治疗。结果治疗组患者FBG（空腹血糖）和2 hBG（餐后2 h血糖）水平降低程度优于对照组（P <0.05），胰岛素用量少于对照组（P <0.05），患者低血糖发生率低于对照组（P <0.05）。结论采用沙格列汀联合门冬胰岛素30注射液治疗老年2型糖尿病疗效显著。
目的：探究老年2型糖尿病採用沙格列汀聯閤門鼕胰島素30註射液治療的臨床療效。方法選取72例老年2型糖尿病患者隨機分為對照組和治療組各組均36例，分彆採用門鼕胰島素30註射液和沙格列汀聯閤門鼕胰島素30註射液治療。結果治療組患者FBG（空腹血糖）和2 hBG（餐後2 h血糖）水平降低程度優于對照組（P <0.05），胰島素用量少于對照組（P <0.05），患者低血糖髮生率低于對照組（P <0.05）。結論採用沙格列汀聯閤門鼕胰島素30註射液治療老年2型糖尿病療效顯著。
목적：탐구노년2형당뇨병채용사격렬정연합문동이도소30주사액치료적림상료효。방법선취72례노년2형당뇨병환자수궤분위대조조화치료조각조균36례，분별채용문동이도소30주사액화사격렬정연합문동이도소30주사액치료。결과치료조환자FBG（공복혈당）화2 hBG（찬후2 h혈당）수평강저정도우우대조조（P <0.05），이도소용량소우대조조（P <0.05），환자저혈당발생솔저우대조조（P <0.05）。결론채용사격렬정연합문동이도소30주사액치료노년2형당뇨병료효현저。
Objective To explore clinical efficacy of elderly patients with type 2 diabetes melitus combined with Shah Glenn Dean Insulin Aspart 30 Injection treatment.Methods 72 cases of elderly patients with type 2 diabetes were randomly divided into control group and treatment group with 36 cases in each group,using insulin aspart 30 injection and Shah Glenn Dean joint Insulin Aspart 30 Injection.Results In the treatment group, the level of FBG (fasting blood glucose) and 2 hBG(postprandial 2 h blood glucose) was better than that of the control group(P < 0.05),Insulin dosage was less than that of the control group(P < 0.05),the incidence of hypoglycemia in patients was lower than that in the control group(P < 0.05).Conclusion The Shah Glenn Dean Insulin Aspart 30 Injection treatment in elderly patients with type 2 diabetes,clinical curative effect is remarkable.
